Diagnostic implications of human cytomegalovirus immediate early-1 and pp67 mRNA detection in whole-blood samples from liver transplant patients using nucleic acid sequence-based amplification

Journal of Clinical Microbiology

Volumn 38, Issue 12, 2000, Pages 4485-4491

  Blok, M J ^a   Lautenschlager, I ^a   Goossens, V J ^a   Middeldorp, J M ^a   Vink, C ^a   Hockerstedt K ^a   Bruggeman, C A ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; GANCICLOVIR; IMMEDIATE EARLY PROTEIN; MESSENGER RNA; METHYLPREDNISOLONE; NUCLEIC ACID; OKT 3; STEROID; TACROLIMUS; VIRUS ANTIGEN;

ADULT; ARTICLE; BIOASSAY; BLOOD ANALYSIS; CLINICAL ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; DRUG MONITORING; GENE AMPLIFICATION; HUMAN; INTERMETHOD COMPARISON; LIVER TRANSPLANTATION; PRIORITY JOURNAL;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; DNA VIRUSES; HUMAN HERPESVIRUS 5;

EID: 0034459556     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.12.4485-4491.2000     Document Type: Article

References (40)

1. Failure of ganciclovir treatment associated with selection of a ganciclovir-resistant cytomegalovirus strain in a lung transplant recipient
2. Monitoring of human cytomegalovirus infections in pediatric bone marrow transplant recipients by nucleic acid sequence-based amplification
3. Cytomegalovirus transcripts in peripheral blood leukocytes of actively infected transplant patients detected by reverse transcription-polymerase chain reaction
4. Early detection of human cytomegalovirus infection after kidney transplantation by nucleic acid sequence-based amplification
5. Diagnostic value of monitoring human cytomegalovirus late pp67 mRNA expression in renal-allograft recipients by nucleic acid sequence-based amplification
6. Rapid and simple method for purification of nucleic acids
7. Detection of mRNA from the immediate early gene of human cytomegalovirus in infected cells by in vitro amplification
8. NASBA and other transcription-based amplification methods for research and diagnostic microbiology
9. Nucleotide sequence of a human cytomegalovirus DNA fragment encoding a 67-kilodalton phosphorylated viral protein
10. Mapping and expression of a human cytomegalovirus major viral protein
11. Banff schema for grading liver allograft rejection: An international consensus document
12. Regulated expression of the human cytomegalovirus pp65 gene: Octamer sequence in the promoter is required for activation by viral gene products
13. Monitoring for cytomegalovirus infection in organ transplant recipients: Analysis of pp65 antigen, DNA and late mRNA in peripheral blood leukocytes
14. Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients
15. Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification
16. Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low-speed centrifugation and monoclonal antibody to an early antigen
17. Monitoring of cytomegalovirus infection and disease in bone marrow recipients by reverse transcription-PCR and comparison with PCR and blood and urine cultures
18. Human cytomegalovirus (HCMV) late-mRNA detection in peripheral blood of AIDS patients: Diagnostic value for HCMV disease compared with those of viral culture and HCMV DNA detection
19. NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection
20. The impact of ganciclovir-resistant cytomegalovirus infection after lung transplantation
21. Significance of reverse transcription polymerase chain reaction in the detection of human cytomegalovirus gene transcripts in thoracic organ transplant recipients
22. Detection of cytomegalovirus by the early-antigen immunofluorescence test versus conventional tissue culture
23. Identification of active cytomegalovirus infection by analysis of immediate-early, early and late transcripts in peripheral blood cells of immunodeficient patients
24. Human cytomegalovirus immediate early and late transcripts in peripheral blood leukocytes: Diagnostic value in renal transplant recipients
25. Risk factors for cytomegalovirus infection after human marrow transplantation
26. Correlation of interstitial pneumonia with human cytomegalovirus-induced lung infection and graft-versus-host disease after bone marrow transplantation
27. A polymerase chain reaction to detect a spliced late transcript of human cytomegalovirus in the blood of bone marrow transplant recipients
28. Infections in solid-organ transplant recipients
29. A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients
30. New molecular assays to predict occurrence of cytomegalovirus disease in renal transplant recipients
31. Circulating immediate-early mRNA in patients with cytomegalovirus infections after solid organ transplantation
32. Preemptive therapy in immunocompromised hosts
33. New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients
34. Structural analysis of the major immediate early gene of human cytomegalovirus
35. Antiviral agents and susceptibility tests
36. The cytomegalovirus antigenemia assay: A plea for standardization
37. Comparison between viremia and antigenemia for detection of cytomegalovirus in blood
38. Detection of cytomegalovirus mRNA and DNA encoding the immediate early gene in peripheral blood leukocytes from immunocompromised patients
39. Cytomegalovirus infections in bone marrow transplant recipients given intensive cytoreductive therapy
40. Cytomegalovirus infections after allogeneic bone marrow transplantation